B Group, Inc. PRAX — PRAXIS PRECISION MEDICINES I

Ownership history in B Group, Inc.  ·  5 quarters on record

AI Ownership Summary

B Group, Inc. reported PRAXIS PRECISION MEDICINES I (PRAX) in 5 quarterly 13F filings from 2025 Q1 through 2026 Q1. Peak portfolio weight reached 7.94% in 2026 Q1. The latest visible filing shows PRAX at 7.94% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this PRAX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was B Group, Inc.'s position in PRAXIS PRECISION MEDICINES I, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

PRAX was reported at 7.94% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
7.94% in 2026 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q1 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

PRAX stock page B Group, Inc. fund profile B Group, Inc. full holdings
How B Group, Inc. held PRAX — position size vs. price
% of Fund (quarterly)    PRAX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 5 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 UNCHANGED — — — 33,237 — 0% 7.94% $10.7M 2026-05-15 $342.58
2025 Q4 ADDED — — — 33,237 +1,737 +5.5% 7.23% $9.8M 2026-02-17 $328.04
2025 Q3 REDUCED 10.0% +474.7% ❌ 31,500 -3,500 -10.0% 1.23% $1.7M 2025-11-14 $186.42
2025 Q2 ADDED — — — 35,000 +16,000 +84.2% 1.13% $1.5M 2025-08-14 $47.70
2025 Q1 INITIATED — — — 19,000 — — 0.62% $720K 2025-05-15 $37.20

🏢 Other funds also holding PRAX

As of 2026 Q1 — sorted by position size

72 Investment Holdings, LLC 3Y 42.83% Velan Capital Investment Management LP 3Y 20.34% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 19.3% Cormorant Asset Management, LP 3Y 7Y 14.33% PERCEPTIVE ADVISORS LLC 3Y 7Y 12.83% KVP Capital Advisors, LP 10.32% Vivo Capital, LLC 3Y 7Y 9.11% Lion Point Capital, LP 3Y 7Y 8.57% Exome Asset Management LLC 7.58% University of Wisconsin Foundation 3Y 7.21%

FAQ About B Group, Inc. and PRAX

These are the practical questions this page is built to answer before you even open the full history table.

How long has B Group, Inc. reported owning PRAX?

B Group, Inc. reported PRAX across 5 quarterly 13F filings, from 2025 Q1 through 2026 Q1.

What was the largest reported PRAX position in B Group, Inc.'s portfolio?

The largest reported portfolio weight for PRAX was 7.94% in 2026 Q1.

What is the latest reported PRAX position on this page?

The most recent filing on this page is 2026 Q1, when B Group, Inc. reported 33,237 shares, equal to 7.94% of portfolio, with an estimated market value of $10.7M.

What does the chart on this PRAX ownership page compare?

The chart compares B Group, Inc.'s quarterly PRAX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did B Group, Inc. time their PRAX position?

Based on 13F filing dates vs. subsequent PRAX price moves, B Group, Inc. correctly timed 3 out of 4 reported position changes (75%). The annualised alpha on PRAX relative to SPY over the holding period was +628.3%.

← Back to B Group, Inc. Holdings